| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017700924 |
| P356 | DOI | 10.1007/S40142-014-0039-5 |
| P932 | PMC publication ID | 4097380 |
| P698 | PubMed publication ID | 25045596 |
| P5875 | ResearchGate publication ID | 262572409 |
| P50 | author | Kristin A Maloney | Q42579886 |
| P2093 | author name string | Toni I Pollin | |
| Stephanie A Stein | |||
| P2860 | cites work | Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1? in human pancreatic development | Q21558580 |
| Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations | Q24308042 | ||
| Leprechaunism: an inherited defect in a high-affinity insulin receptor | Q24675667 | ||
| WFS1-Related Disorders | Q26865734 | ||
| Activating mutations in the ABCC8 gene in neonatal diabetes mellitus | Q27863930 | ||
| Genetic cause of hyperglycaemia and response to treatment in diabetes | Q28212185 | ||
| Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome | Q28255356 | ||
| Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes | Q28272915 | ||
| Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population | Q28284936 | ||
| Standards of medical care in diabetes--2014 | Q28304435 | ||
| HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families | Q30411842 | ||
| Genetics of type 1 diabetes: what's next? | Q30431554 | ||
| Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene | Q30466668 | ||
| Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome. | Q30478819 | ||
| Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth | Q30548217 | ||
| Prediction and interaction in complex disease genetics: experience in type 1 diabetes | Q33479555 | ||
| The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease | Q33646822 | ||
| Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update | Q33806347 | ||
| Genetic risk profiling for prediction of type 2 diabetes | Q33807014 | ||
| Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study | Q33912545 | ||
| Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome | Q33929788 | ||
| Predictors of postpartum diabetes in women with gestational diabetes mellitus | Q33993826 | ||
| Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus | Q34061740 | ||
| Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young | Q34092827 | ||
| Genomic imprinting in diabetes | Q34152893 | ||
| Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. | Q34254404 | ||
| Management of diabetes mellitus by obstetrician-gynecologists | Q34323927 | ||
| Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies | Q34360980 | ||
| Meta-analysis of the relationship between common type 2 diabetes risk gene variants with gestational diabetes mellitus | Q34430295 | ||
| Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. | Q34461739 | ||
| Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment | Q34469916 | ||
| Metabolic effects of metformin in non-insulin-dependent diabetes mellitus | Q34720764 | ||
| Hyperglycemia and adverse pregnancy outcomes | Q34777029 | ||
| Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: common genetic variants in GCK and TCF7L2 are associated with fasting and postchallenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from | Q34876993 | ||
| Inherited destiny? Genetics and gestational diabetes mellitus | Q34971477 | ||
| Genes, growth factors and acanthosis nigricans. | Q35009490 | ||
| First UK survey of paediatric type 2 diabetes and MODY | Q35279552 | ||
| Reducing insulin resistance with metformin: the evidence today | Q35539934 | ||
| Neonatal and very-early-onset diabetes mellitus | Q35687894 | ||
| The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants | Q35860268 | ||
| Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young | Q35976364 | ||
| Molecular mechanisms of mitochondrial diabetes (MIDD). | Q36194894 | ||
| Association of variants in PPARγ², IGF2BP2, and KCNQ1 with a susceptibility to gestational diabetes mellitus in a Korean population. | Q36620356 | ||
| Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management | Q36812405 | ||
| Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. | Q37080105 | ||
| Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes | Q37095214 | ||
| GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome | Q37213617 | ||
| The diagnosis and management of monogenic diabetes in children and adolescents | Q37597454 | ||
| Evaluation of a target region capture sequencing platform using monogenic diabetes as a study-model | Q37619901 | ||
| Rabson-Mendenhall syndrome: two case reports and a brief review of the literature | Q37692279 | ||
| Role of molecular genetics in transforming diagnosis of diabetes mellitus | Q37861231 | ||
| Diabetes and pregnancy: an endocrine society clinical practice guideline | Q38160216 | ||
| Clinical utility gene card for: Transient Neonatal Diabetes Mellitus, 6q24-related | Q42796381 | ||
| Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3. | Q43073998 | ||
| Mutations in hepatocyte nuclear factor-1beta and their related phenotypes | Q43167987 | ||
| The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort | Q43416942 | ||
| Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients. | Q43825665 | ||
| Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. | Q45142819 | ||
| Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. | Q45953524 | ||
| Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes | Q46810133 | ||
| Mutations in the glucokinase gene of the fetus result in reduced placental weight | Q46815627 | ||
| Peroxisome proliferator-activated receptor gamma coactivator-1alpha gene variations are not associated with gestational diabetes mellitus | Q46916835 | ||
| Insulin effect during embryogenesis determines fetal growth: a possible molecular link between birth weight and susceptibility to type 2 diabetes | Q47250275 | ||
| Mutations in the glucokinase gene of the fetus result in reduced birth weight | Q47285449 | ||
| Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction | Q47690661 | ||
| Mutations in hepatocyte nuclear factor 1beta are not a common cause of maturity-onset diabetes of the young in the U.K. | Q47903942 | ||
| KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features | Q48557897 | ||
| A conserved imprinting control region at the HYMAI/ZAC domain is implicated in transient neonatal diabetes mellitus | Q48561080 | ||
| Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. | Q50646471 | ||
| The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome. | Q51326013 | ||
| Treating diabetes mellitus in Prader-Willi syndrome with Exenatide. | Q51517764 | ||
| A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. | Q51551572 | ||
| Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. | Q51579882 | ||
| Identification of glucokinase mutations in subjects with gestational diabetes mellitus. | Q51600269 | ||
| Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes. | Q51600754 | ||
| Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. | Q51674489 | ||
| Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment. | Q54946696 | ||
| Diagnosis and Classification of Diabetes Mellitus | Q56001184 | ||
| RabsonMendenhall syndrome | Q56864106 | ||
| High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population | Q57920422 | ||
| Maturity-onset diabetes of the young (MODY): how many cases are we missing? | Q57920457 | ||
| Heterozygous ABCC8 mutations are a cause of MODY | Q57920463 | ||
| Mutations in the hepatocyte nuclear factor-1α gene in Caucasian families originally classified as having Type I diabetes | Q58201282 | ||
| Mutations in the Hepatocyte Nuclear Factor-1 Gene Are a Common Cause of Maturity-Onset Diabetes of the Young in the U.K | Q63353075 | ||
| Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes | Q63916552 | ||
| Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed? | Q71482556 | ||
| Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families | Q73108256 | ||
| Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes | Q74102330 | ||
| Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism | Q74189167 | ||
| Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes | Q74266383 | ||
| Influence of maternal and fetal glucokinase mutations in gestational diabetes | Q74307560 | ||
| Molecular Genetics of Maturity-onset Diabetes of the Young | Q77735613 | ||
| A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus | Q79889453 | ||
| Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene | Q84371316 | ||
| Inconsistent Results, Inaccurate Claims Plague Direct-to-Consumer Gene Tests | Q85063244 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 56-67 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Current genetic medicine reports | Q27724648 |
| P1476 | title | Genetic Counseling for Diabetes Mellitus | |
| P478 | volume | 2 |
| Q55338790 | Association of NF-E2 Related Factor 2 (Nrf2) and inflammatory cytokines in recent onset Type 2 Diabetes Mellitus. |
| Q90256971 | Patient perspectives on the diagnostic journey to a monogenic diabetes diagnosis: Barriers and facilitators |
| Q35779453 | Personalized medicine in diabetes mellitus: current opportunities and future prospects |
| Q33898977 | The Genetic Architecture of Diabetes in Pregnancy: Implications for Clinical Practice. |
| Q28083025 | Undiagnosed MODY: Time for Action |
| Q41646229 | User-centered design of multi-gene sequencing panel reports for clinicians |
Search more.